MedicarePartD.guide

A non-government resource built from CMS public data

Osteoporosis drugs on every 2026 Arkansas Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Arkansas cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

Osteoporosis drugs by 2026 Arkansas Part D plan
DrugWellcare Classic$0.00/moS4802-073Wellcare Value Script$0.00/moS4802-153HealthSpring Assurance Rx$0.00/moS5617-225Humana Basic Rx Plan$0.00/moS5884-141Humana Value Rx Plan$0.00/moS5884-198BlueMedicare Value Rx$52.50/moS5795-003HealthSpring Extra Rx$54.50/moS5617-369AARP Medicare Rx Saver from UHC$65.10/moS5921-364SilverScript Choice$73.50/moS5601-038Humana Premier Rx Plan$92.40/moS5884-165AARP Medicare Rx Preferred from UHC$114.90/moS5921-400BlueMedicare Premier Rx$181.20/moS5795-002
alendronategeneric FosamaxTier 1$0.00QL 30/30dTier 1$0.00QL 30/30dTier 15%QL 30/30dTier 2$1.00QL 30/30dTier 1$0.00QL 30/30dTier 1$0.00Tier 1$0.00Tier 2$7.00QL 30/30dTier 1$0.00Tier 1$0.00QL 30/30dTier 1$5.00QL 30/30dTier 1$0.00
risedronategeneric ActonelNot coveredTier 2$3.00QL 1/30dNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 433%QL 1/28dNot coveredNot coveredNot covered
ibandronategeneric BonivaTier 325%QL 1/30dTier 2$3.00QL 1/30dTier 325%QL 1/28dTier 325%QL 1/28dTier 320%QL 1/28dTier 3PA19%Tier 317%QL 1/28dTier 318%QL 1/28dTier 433%QL 1/30dTier 3$45.00QL 1/28dTier 316%QL 1/28dTier 2PA$5.00
ProliadenosumabNot coveredNot coveredTier 429%QL 1/180dTier 434%QL 1/180dTier 433%QL 1/180dTier 434%QL 1/180dTier 431%QL 1/180dNot coveredNot coveredTier 450%QL 1/180dNot coveredTier 434%QL 1/180d
denosumab biosimilarsJubbonti, Ospomyv and othersTier 426%QL 1/180dTier 440%QL 1/180dNot coveredNot coveredNot coveredTier 434%QL 1/180dNot coveredTier 432%QL 1/180dTier 433%QL 1/180dNot coveredTier 429%QL 1/180dTier 434%QL 1/180d
EvenityromosozumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ForteoteriparatideNot coveredNot coveredNot coveredTier 5PA25%QL 2.24/28dTier 5PA26%QL 2.24/28dNot coveredNot coveredNot coveredNot coveredTier 5PA33%QL 2.24/28dNot coveredNot covered
teriparatidegeneric ForteoTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dNot coveredNot coveredTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%QL 2.48/28dTier 5PA25%Not coveredTier 5PA31%QL 2.48/28dTier 5PA33%QL 2.48/28d
TymlosabaloparatideNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 1.56/30dNot coveredNot coveredTier 5PA25%Not coveredTier 5PA31%QL 1.56/30dTier 5PA33%QL 1.56/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.